How much is Kinnate Biopharma worth in 2026?

Kinnate Biopharma has a current valuation of N/A based on their Later Stage VC (Series C) round and secondary market data.

How much funding has Kinnate Biopharma raised?

Kinnate Biopharma has raised N/A in total funding across 1 funding rounds.

Kinnate Biopharma

Drug Discovery

Kinnate Biopharma valuation and funding history | Last updated: August 26, 2020 | 1 funding rounds

Current Valuation

N/A

As of August 26, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series C)

$98.0M

Last Funding

Aug 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 26, 2020	Later Stage VC (Series C)	$98.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Kinnate Biopharma is currently valued at N/A as of August 26, 2020.

Track Kinnate Biopharma Valuation Updates

Get notified when Kinnate Biopharma raises new funding or valuation changes

Explore More Data

Detailed analysis for Kinnate Biopharma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Kinnate Biopharma's valuation history, funding rounds, and growth metrics.

No credit card required

What is Kinnate Biopharma Worth in 2026?

Kinnate Biopharma is a leading private company in the Drug Discovery sector. Track Kinnate Biopharma's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Kinnate Biopharma Valuation is Determined

Private company valuations like Kinnate Biopharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.